Chemical Probes of Rapid Estrogen Signaling in Breast Cancer Treatment and Chemoprevention

作者: Ross V. Weatherman

DOI: 10.21236/ADA455792

关键词:

摘要: Abstract : The goal of this project was to design new chemical tools selectively probe the molecular mechanisms action rapid estrogen receptor and their relevance breast cancer drugs like tamoxifen. Over course project, we synthesized tested approximately 15 modulators, some with novel activity in terms both classic transcriptional response modulation. We discovered that structure relationship for responses is different than SAR required regulation, but could not be separated from a metabolite tamoxifen, called endoxifen, which appears major bioactive tamoxifen women. This work also resulted letter FDA concerning possible drug interactions between women taking certain antidepressants. made polymer-based conjugate 4-hydroxytamoxifen only shows great uptake into ER positive cells, antiproliferative against antiestrogen sensitive antiestrogen- resistant cell lines. are currently trying translate unexpected finding experimental therapeutics treatment tamoxifen-resistant cancer, an urgent need patients.

参考文章(16)
Wenlin Shao, Myles Brown, Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy Breast Cancer Research. ,vol. 6, pp. 39- 52 ,(2003) , 10.1186/BCR742
Meiyun Fan, Xinghua Long, Jason A. Bailey, Chad A. Reed, Elizabeth Osborne, Edward A. Gize, Eric A. Kirk, Robert M. Bigsby, Kenneth P. Nephew, The Activating Enzyme of NEDD8 Inhibits Steroid Receptor Function Molecular Endocrinology. ,vol. 16, pp. 315- 330 ,(2002) , 10.1210/MEND.16.2.0778
Ya-Ling Wu, Xiaojing Yang, Zhong Ren, Donald P. McDonnell, John D. Norris, Timothy M. Willson, Geoffrey L. Greene, Structural basis for an unexpected mode of SERM-mediated ER antagonism Molecular Cell. ,vol. 18, pp. 413- 424 ,(2005) , 10.1016/J.MOLCEL.2005.04.014
C K Osborne, A Wakeling, R I Nicholson, Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action. British Journal of Cancer. ,vol. 90, ,(2004) , 10.1038/SJ.BJC.6601629
Timothy M Willson, Brad R Henke, Tanya M Momtahen, Paul S Charifson, Kenneth W Batchelor, Dennis B Lubahn, Linda B Moore, Beverly B Oliver, Howard R Sauls, James A Triantafillou, Steven G Wolfe, Philip G Baer, None, 3-[4-(1,2-Diphenylbut-1-enyl)phenyl]acrylic acid: a non-steroidal estrogen with functional selectivity for bone over uterus in rats. Journal of Medicinal Chemistry. ,vol. 37, pp. 1550- 1552 ,(1994) , 10.1021/JM00037A002
Ashini L. Wijayaratne, Susan C. Nagel, Lisa A. Paige, Dale J. Christensen, John D. Norris, Dana M. Fowlkes, Donald P. McDonnell, Comparative analyses of mechanistic differences among antiestrogens. Endocrinology. ,vol. 140, pp. 5828- 5840 ,(1999) , 10.1210/ENDO.140.12.7164
Ashley C.W. Pike, A.Marek Brzozowski, Julia Walton, Roderick E. Hubbard, Ann-Gerd Thorsell, Yi-Lin Li, Jan-Åke Gustafsson, Mats Carlquist, Structural insights into the mode of action of a pure antiestrogen. Structure. ,vol. 9, pp. 145- 153 ,(2001) , 10.1016/S0969-2126(01)00568-8
Ross V Weatherman, Nicola J Clegg, Thomas S Scanlan, Differential SERM activation of the estrogen receptors (ERα and ERβ) at AP-1 sites Chemistry & Biology. ,vol. 8, pp. 427- 436 ,(2001) , 10.1016/S1074-5521(01)00025-4